Hi pooman,
Agree on most of you say.
Regarding the point on expenses, I think there are two different elements :
- paid acquisitions : I agree. It is a bit strange to reproach to a growth company to invest to get more customers. I think we should probably look at paid acquisitions, together with top line growth. As long as paid acquisitions support the top line growth, I don't see why it is a problem;
- gross margin : that was disappointing. The decrease qoq was significant. The company explained it and saw it as a one off. The main point for me was that they gave a guidance for future gross margin, while they are very reluctant to give any clear guidance usually.
One of the question I have at this stage is about the volume of transactions when they published (more than 5 % of the capital if I remember well). Not clear who was selling such volumes, as we had no change of substantial holders (on the sell side) so far.
- Forums
- ASX - By Stock
- ATG
- REFLECTIONS ON LAST WEEKS SP ACTION
ATG
articore group limited
Add to My Watchlist
2.44%
!
20.0¢

REFLECTIONS ON LAST WEEKS SP ACTION, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $56.91M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 20.0¢ | $1.031K | 5.122K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4886 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 24500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4886 | 0.200 |
2 | 29999 | 0.190 |
3 | 46626 | 0.185 |
1 | 40000 | 0.180 |
3 | 39900 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 24500 | 2 |
0.230 | 44881 | 2 |
0.235 | 55918 | 2 |
0.240 | 681 | 1 |
0.245 | 7500 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ATG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online